For foreign Emerging Stock Board enterprises, ”*- country of incorporation” indicates stocks without par value or with par value other than NT$10, and ”- country of incorporation” indicates stocks with par value of NT$10 per share.
|
Basic information |
Chairman |
President |
Spokesperson |
Telephone |
Address |
ESM Registration Date |
Tzu-Ling (Karen) Tseng |
Tzu-Ling (Karen) Tseng |
Tsuhsun, Kuo (Eric Kuo) |
(03)560-1816 |
6F-1, No. 18 Taiyuan St.Zhubei City, Hsinchu County, Taiwan |
2021/08/30 |
Industrycategory |
Key businesses |
Biotechnology and Medical Care |
Bio Preventive Medicine (BPM) is a leading company in renal biomarker area. As an innovative and clinical staged biotech company, BPM has focus on translating validated and IP-protected biomarkers into diagnostic solutions for unmet clinical needs, especially among the fields of disease’s early detection and prevention in diabetes related complications, such as CKD and CVD, kidney injury, and oncology (upper GI cancer).
To advance precision medicine and reduce healthcare burden globally in chronic diseases and oncology, BPM develops clinically proven biomarkers and high value-added diagnostic products, that enable unprecedented efficiencies in the development of therapies. BPM constantly contribute its expertise and is seeking to partner and collaborate with leading industry organizations. |
Financial data |
Cash flows statement
| Item
|
|
|
Amount(NTD, in thousands) |
Cash flows from operating activities |
|
|
Cash flows from investing activities |
|
|
Cash flows from financing activities |
|
|
Consolidated/Individual balance sheet
|
Current assets |
|
|
Non-current assets |
|
|
Total assets |
|
|
Current liabilities |
|
|
Non-current liabilities |
|
|
Total liabilities |
|
|
Share capital |
|
|
Capital surplus |
|
|
Retained earnings |
|
|
Other equity interest |
|
|
Treasury shares |
|
|
Total equity attributable to owners of parent |
|
|
Non-controlling interests |
|
|
Total equity |
|
|
Book Value per share(NT$) |
|
|
Consolidated/Individual profit and loss statement |
Operating revenue |
|
|
Operating costs |
|
|
Gross profit from operations |
|
|
Operating expenses |
|
|
Net other income (expenses) |
|
|
Net operating income |
|
|
Non-operating income and expenses |
|
|
Profit before tax |
|
|
Tax expense |
|
|
Profit from continuing operations |
|
|
Profit from discontinued operations |
|
|
Profit |
|
|
Other comprehensive income |
|
|
Comprehensive income |
|
|
Basic earnings per share |
|
|
Auditor's report on latest financial statements: auditor's report:
|
Investors may find more detailed information on the company by visiting the Market Observation Post System.。
|
The information disclosed here concerning foreign enterprises consists of amounts provided in consolidated financial statements.
|